CUSIP: 92673K108
Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46,698,729
-
Total 13F shares
-
17,859,665
-
Share change
-
+17,857,214
-
Total reported value
-
$125,101,000
-
Price per share
-
$7.03
-
Number of holders
-
47
-
Value change
-
+$125,084,000
-
Number of buys
-
46
Quarterly Holders Quick Answers
What is CUSIP 92673K108?
CUSIP 92673K108 identifies VIGL - Vigil Neuroscience, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92673K108:
Institutional Holders of Vigil Neuroscience, Inc. - Common Stock (VIGL) as of Q1 2022
As of 31 Mar 2022,
Vigil Neuroscience, Inc. - Common Stock (VIGL) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,859,665 shares.
The largest 10 holders included
Atlas Venture Life Science Advisors, LLC, Northpond Ventures, LLC, CITADEL ADVISORS LLC, Artal Group S.A., Cormorant Asset Management, LP, Pivotal bioVenture Partners Investment Advisor LLC, Rock Springs Capital Management LP, ORBIMED ADVISORS LLC, Deep Track Capital, LP, and VANGUARD GROUP INC.
This page lists
47
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.